Home Page About Us People Committees Membership Meetings News For Patients For Members

About The American Society for Reconstructive Transplantation

The ASRT was founded on July 9th, 2008. The overall goal of the society is to provide a platform for the advancement of education, science and practice of reconstructive transplant surgery. The guiding principle of the Society is to provide members and visitors with a concept that enables and encourages everybody with an interest in Reconstructive Transplantation to participate towards our goal of promoting progress and information exchange in this growing field.

Membership in The American Society for Reconstructive Microsurgery provides access to:

*A panel of Experts in Transplant Immunology and Reconstructive Transplantation for consultation and establishment of multi-disciplinary trials
*A platform for communication and information exchange with all members
*A large body of information provided on the website of the Society
*Information and documents required to set up a Composite Tissue Transplant Program

News


Penn Medicine Performs Bilateral Hand Transplant
On November 2, a press conference was held at the Hospital of the University of Pennsylvania to publicly announce the first bilateral hand transplant performed by Penn Medicine and the first in the region. The procedure was successfully performed by a team of 30 – 12 surgeons, three anesthesiologists and 15 nurses – from the Penn Hand Transplant Program within the Penn Transplant Institute. The team included experts in solid organ transplantation, orthopaedic surgery, plastic surgery, reconstructive microsurgery, and anesthesia. Penn worked close with their partners at Gift of Life Donor Program to begin Penn’s first venture in to the emerging field of Vascularized Composite Allotransplantation. The first procedure, performed in September on a female quadruple amputee, took 11 and one-half hours to complete.

Senator John Boozman
ASRT in Washington, D.C.
ASRT leadership and committee chairs met with key Washington figures on June 9th to state our position on Vascularized Composite Allografts in regards to tissue versus organ.